16 results on '"Peters, Mary Linton Bounetheau"'
Search Results
2. Financial toxicity in patients with newly diagnosed hepatocellular carcinoma.
3. PD-L1 as a predictor of chemo-immunotherapy response in biliary tract cancers: A systematic review and meta-analysis.
4. Number of subsequent treatments and time to recurrence in hepatocellular carcinoma.
5. Comparison of neoadjuvant treatment modalities for locally advanced intrahepatic cholangiocarcinoma.
6. Immunohistochemical and genetic profiles do not predict behavior of mixed hepatocellular intrahepatic cholangiocarcinoma.
7. Uptake in genetic testing in patients with pancreatic cancer with oncologist-driven testing protocol.
8. Cascade testing of first-degree relatives of patients with pancreatic cancer with confirmed germline genetic mutations: A simulation modeling study.
9. A phase I study of LY3410738, a first-in-class covalent inhibitor of mutant IDH1 in cholangiocarcinoma and other advanced solid tumors.
10. Time to COVID-19 RT-PCR clearance among patients with cancer.
11. Association of immune related adverse events with superior outcomes in patients with hepatocellular carcinoma (HCC) treated with nivolumab.
12. GI oncology molecular tumor board: Fostering collaboration and clinical education for personalized therapy.
13. Comparison of the clinical features, treatment patterns, and tumor mutations of patients with intrahepatic (ICC) and extrahepatic (ECC) cholangiocarcinoma.
14. Germline genetic testing in unselected pancreatic ductal adenocarcinoma (PDAC) patients.
15. Molecular profiling as a predictor of treatment response and survival in unresectable pancreatic ductal adenocarcinoma.
16. COVID-19 clearance among patients with cancer during the Delta and Omicron waves.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.